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ABSTRACT 
This WHO guidelines present general consideration on potentially hazardous contaminants and residues in herbal 
medicines and include guiding principles of assessing quality of herbal medicines in terms of major contaminants and 
residues. It also recommends analytical methods for qualitative and quantitative determination of such contaminants 
and residues. 
Within  overall  context  of  quality  assurance  these  guidelines  intended  to  provide  general  technical  guidance  to 
Member state in assessing quality relating to safety of herbal materials and products classified as medicines with 
regards to major and common contaminants and residues. 
The objectives of these guidelines are to provide: 
Ø Guiding principle for assessing the quality in relation  to the safety of herbal medicines with specific  reference to 
contaminants and residues 
Ø Model criteria for use in identifying possible contaminants and residues 
Ø Example of methods and techniques and 
Ø Example of practical procedures for controlling the quality of finished herbal products. 
The scope of these guidelines does not cover issues of adulteration of herbal medicines and/or counterfeit products. 
The annexes to these guidelines present several example of suitable methodologies found in national or regional 
pharmacopoeias and WHO documents it should be noted that these methods need to be validated for the material that 
is to be tested and also for each type of instruments. 
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INTRODUCTION 
Because  of  the  increase  use  of  herbal  medicine 
worldwide and herbal products make the global market 
for their use globally, the safety and quality of medicinal 
plants and finished herbal products have become a major 
concern  for health authorities, pharmaceuticals and the 
public. 
National regulation and registration of herbal medicines 
varies from country to country. Where herbal medicines 
are regulated, they are categorized either as prescription 
or  non  prescription  medicines.  Herbal  products 
categorized  other  than  as  medicines  and  foods,  are 
become  increasingly  popular  and  there  potential  for 
adverse events due to lack of regulation. 
The  international  conference  of  Drug  Regulatory 
Authorities (ICDRA) at its 9
th, 10
th and 11
th meetings of 
the  national  centers  participating  in  the  WHO  Drug 
Monitoring Programme requested WHO to develop and 
constantly  update  the  technical  guidelines  on  quality 
safety and efficacy of herbal medicines.
1 
The  participants  at  the  WHO  informal  meeting  on 
methodologies  for  quality  control  of  finished  herbal 
products, held in Ottawa, Canada, 20-21 july 2001, also 
reviewed  the  entire  production  process  of  herbal 
medicines, from raw materials to distribution and supply 
of finished herbal products. Recommendation from these 
meetings  led  to  the  development  of  these  general 
guidelines addressing the important issues of safety and 
quality  of  herbal  medicines  with  special  reference  to 
contaminants and residues. 
Objectives 
Within  the  overall  context  of  quality  assurance,  these 
guidelines  are  primarily  intended  to  provide  general 
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quality related to safety of herbal medicines with regard 
to both major and common contaminants and residues. 
These guidelines may need to be adjusted according to 
each country’s situation 
The objectives of these guidelines are to provide: 
Ø Guiding principle for assessing the quality in relation  
to  the  safety  of  herbal  medicines  with  specific  
reference to contaminants and residues 
Ø Model  criteria  for  use  in  identifying  possible 
contaminants and residues 
Ø Example of methods and techniques and 
Ø Example  of  practical  procedures  for  controlling  the 
quality of finished herbal products. 
In the pursuit of the above-mentioned objectives, these 
guidelines should be read together with the other WHO 
documents and publications (including  future versions) 
relating to the quality assurance of herbal medicines with 
regard to safety, for example (for details see reference 
list): 
ü Quality control methods for medicinal plant material.
2 
ü Good agricultural and collection practices (GACP) for 
medicinal plants.
3 
ü International pharmacopoeia, 4
th ed.
4,5 
ü Good  manufacturing  practices:  main  principles  for 
pharmaceutical products.
6 
ü Good  manufacturing  practices:  supplementary 
guidelines  for  the  manufacture  of  herbal  medicinal 
products.
7 
ü Guide to good storage practices for pharmaceuticals.
8 
ü Good  trade  and  distribution  practices  (GTDP)  for 
pharmaceutical starting materials.9 
ü General  guidelines  for  methodologies  on  research 
and evaluation of traditional medicine.
10 
ü Guidelines for assessment of herbal medicines.
11 
ü WHO monographs on selected medicinal plants.
12,13 
ü Codex  Alimentarius  code  of  practice,  general 
principles of food hygiene.
14 
ü Codex  Alimentarius  guidelines  for  the  production, 
processing,  labeling  and  marketing  of  organically 
produced foods.
15 
ü Codex  Alimentarius code of practice  for spices  and 
dried aromatic plants.
16 
Important terms 
Relating to the herbal medicines 
The terms and their deﬁnitions have been selected and 
adopted from other WHO documents and guidelines that 
are widely used by WHO Member States.  Deﬁnitions of 
the terms may differ from those adopted in regulations 
and/or  in  common  usage  in  some  Member  States. 
However, one of the purposes of these deﬁnitions is to 
provide consistency  in terminology with other relevant 
WHO documents in this ﬁeld, such as the WHO General 
guidelines for methodologies on research and evaluation 
of traditional  medicine and WHO Good manufacturing 
practices. It should also be noted that these deﬁnitions 
have  been  developed  to  meet  the  demand  for  the 
establishment  of  standard,  internationally  acceptable 
deﬁnitions to be used in the evaluation and research of 
herbal medicines.
10 
Herbal  medicines:  These  include  herbs,  herbal 
materials,  herbal  preparations  and  ﬁnished  herbal 
products.
10 
Herbs:  Herbs  include  crude  plant  material  such  as 
leaves,  ﬂowers,  fruit,  seeds,  stems,  wood,  bark,  roots, 
rhizomes  or  other  plant  parts,  which  may  be  entire, 
fragmented or powdered.
10 
Herbal  materials:  Herbal  materials  are  either  whole 
plants  or  parts  of  medicinal  plants  in  the  crude  state. 
They  include  herbs,  fresh  juices,  gums,  ﬁxed  oils, 
essential oils, resins and dry powders of herbs. In some 
countries, these materials may be processed by various 
local  procedures,  such  as  steaming,  roasting,  or  stir 
baking  with  honey,  alcoholic  beverages  or  other 
materials.
10 
Herbal preparations: Herbal preparations are the basis 
for  ﬁnished  herbal  products  and  may  include 
comminuted or powdered herbal  materials, or extracts, 
tinctures and fatty oils, expressed juices and processed 
exudates of herbal materials. They are produced with the 
aid  of  extraction,  distillation,  expression,  fractionation, 
puriﬁcation,  concentration,  fermentation  or  other 
physical  or  biological  processes.  They  also  include 
preparations  made  by  steeping  or  heating  herbal 
materials in alcoholic beverages and/or honey, or in other 
materials.
10 
Finished  herbal  products:  Medicinal  products 
containing as active substances exclusively herbal drugs 
or herbal drug preparations. They may consist of herbal 
preparations made from one or more herbs. If more than 
one herb is used, the term mixed herbal product can also 
be used. They may contain excipients in addition to the 
active  ingredients.  In  some  countries  herbal  medicines 
may contain,  by tradition,  natural organic or inorganic 
active  ingredients,  which  are  not  of  plant  origin  (e.g. 
animal  materials  and  mineral  materials).  Generally 
however, ﬁnished products or mixed products to which 
chemically deﬁned active substances have been added, 
including  synthetic  compounds  and/or  isolated 
constituents from herbal materials, are not considered to 
be herbal.
10 
Medicinal  plants:  A  plant,  either  growing  wild  or 
cultivated, used for its medicinal purposes.
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Relating to the contaminants and residues in herbal 
medicines: 
In general the following terms and their explanations as 
they  relate  to  contaminants  and  residues  in  herbal 
medicines  have  been  adopted  verbatim  or  where 
necessary  adapted  from  the  deﬁnitions  for  pesticide 
residues in foods, developed by the Codex Alimentarius 
Commissio  and  the  Joint  FAO/WHO  Meeting  on 
Pesticide Residues. Thus when Member States consider 
the  terms  relevant  to  their  individual  needs,  these 
documents  should  be  consulted.  The  reason  for  this 
suggestion  is  that  in  future  the  Joint  FAO/WHO 
Meetings  on  Pesticide  Residues(JMPR)  will  probably 
continue as the group mandated to evaluate the safety of 
pesticides and the Joint FAO/WHO Expert Committee 
on Food Additives (JECFA) for contaminants in herbal 
medicines and in foods. 
Contamination:  The  undesired  introduction  of 
impurities of a chemical or microbiological nature, or of 
foreign  matter,  into  or  onto  a  starting  material, 
intermediate product or 
Finished  herbal  product  during  production,  sampling, 
packaging or repackaging, 
Storage or transport.
6 
Cross-contamination: The contamination of a  starting 
material, intermediate product or finished product with 
another starting material or product during production.
6 
Foreign matter: Material consisting of any or all of the 
following: 
o  parts of the medicinal plant material or materials other 
than  those  named  with  the  limits  speciﬁed  for  the 
plant material concerned; 
o  any organism, part or product of an organism, other 
than that  named  in the and description of the plant 
material concerned; 
o  mineral  admixtures  such  as  soil,  stones,  sand,  and 
dust;  and  glass,  metal  and  plastics  or  any  other 
extraneous materials. These may be loose or adhering 
to these medicinal plant material.
2 
Acceptable daily intake (ADI) of a chemical: A daily 
intake,  which,  during  an  entire  lifetime,  appears  to  be 
without appreciable risk to the health of the consumer, 
on the  basis of all the known  facts at the time of the 
evaluation  of  the  chemical  by  the  Joint  FAO/WHO 
Meeting  on  Pesticide  Residues.  It  is  expressed  in 
milligrams of the chemical per kilogram of body 
weight.
21 
Acceptable residual level (ARL): The ARL is given in 
mg of pesticide per kg of medicinal plant material and 
can  be  calculated  from  the  maximum  acceptable  daily 
intake  (ADI)  of  the  pesticide  for  humans,  as 
recommended  by  FAO and  WHO, and the  mean daily 
intake (MDI) of 
the medicinal plant material.
21 
Acute  reference  dose  (ARD):  ARD  is  the  amount  of 
pesticide to which a person is exposed, usually, at one 
day’s regimen of herbal medicines and which results in 
acute  effects  on  the  human  body.  ARD  estimations 
include a safety factor to ensure that the elderly, infants, 
children  and  those  whose  systems  are  under  stress 
because of illness, are protected.
21 
Extraneous  maximum  residue  limits  (EMRL): 
Apesticide  residue  or  a  contaminant  arising  from 
environmental  sources  (including  former  agricultural 
uses) other than the use of  a pesticide or contaminant 
substance directly or indirectly on the herbal medicine. 
The concentration is expressed in milligrams of pesticide 
residue  or  contaminant  per  kilogram  of  the  herbal 
medicine.
21 
Maximum  Residual  limit  (MRL):  The  MRL  is  the 
maximum concentration of a pesticide residue (expressed 
as  mg/  kg)  recommended  by  the  Codex  Alimentarius 
Commission  to  be  legally  permitted  (in  food 
commodities  and  animal  feeds).  MRLs  are  based  on 
good  agricultural  practices  (GAP)  data  established  for 
foods, and foods derived from commodities that comply 
with  the  respective  MRLs  are  intended  to  be 
toxicologically acceptable.
21 
Permitted  daily  exposure:  The  term  “permitted  daily 
exposure” (PDE) is deﬁned, in the ICH guidelines, as a 
pharmaceutically acceptable  intake of residual  solvents 
to  avoid  confusion  of  differing  ADIs  for  the  same 
substance.
22 
Pesticides:  For  the  purpose  of  these  guidelines, 
pesticides  are  deﬁned  as  any  substance  intended  for 
preventing,  destroying,  attracting,  repelling,  or 
controlling any pest including unwanted species of plants 
or  animals  during  production,  storage,  transport, 
distribution  and  processing.  The  term  includes 
substances intended for use as a plant-growth regulator, 
defoliant,  desiccant,  fruit  thinning  agent,  or  sprouting 
inhibitor and substances applied to crops either before or 
after harvest to protect the commodity from deterioration 
during storage and transport. The term normally excludes 
fertilizers and plant nutrients.
21 
Pesticides residue: Pesticide residues are any speciﬁed 
substance  in  food,  agricultural  commodities  or  animal 
feed  resulting  from  the  use  of  a  pesticide.  The  term 
includes  any  derivatives  of  a  pesticide,  such  as 
conversion products, metabolites, reaction products and 
impurities  considered  to  be  of  toxicological 
signiﬁcance.
21 Patel Parthik et al / IJRAP 2011, 2 (4) 1148-1154 
International Journal of Research in Ayurveda & Pharmacy, 2(4), 2011  1148-1154 
Persistent  organic  pollutants  (POPs):  Persistent 
organic pollutants (POPs) are chemical substances that 
persist  in  the  environment,  bioaccumulate  through  the 
food web and pose a risk of causing adverse effects to 
human health and the environment. With the evidence of 
long-  range  transport  of  these  substances  to  regions 
where they have never been used or produced and the 
consequent threats they pose to the environment of the 
whole globe, the international community has, on several 
occasions, called for urgent global action to reduce and 
eliminate releases of these chemicals. 
Tolerable  intake:  Tolerable  intake  is  deﬁned  as  an 
estimate of the intake of a substance over a lifetime that 
is considered to be without appreciable health risk.
23 
Residue solvents: These are residues of organic solvents 
that  are  used  or  produced  in  the  manufacture  of  and 
processing of herbal preparations/products. Solvents are 
classiﬁed by the ICH (CPMP/ICH 283/95) according to 
their potential risk into: 
· class 1 (solvents to be avoided such as benzene); 
· class  2  (limited  toxic  potential  such  as  methanol  or 
hexane); and 
· class 3 (low toxic potential such as ethanol). 
Guidelines  for  assessing  safety  of  herbal  medicines 
with reference to contaminants and residue 
Determination of arsenic and toxic metals 
In  general,  quantitative  tests  and  limit  tests  accurately 
determine the concentrations of toxic metals in the form 
of  impurities  and  contaminants.  The  latter  are 
unavoidably  present  in  the  samples  being  tested  i.e. 
herbal medicines and their herbal products.
34 See Table 
no. 2
 
In  general,  if  the  heavy  metals  burden  of  the  herbal 
material is unknown, it is suggested that it be determined 
qualitatively  and  quantitatively  on  several  batches 
preferably  collected  over  several  years.  These  data 
should be used to establish acceptance limits that should 
be checked by appropriate limit tests.
32 
Determination of radioactive contaminants 
Method of measurement 
Following  a  severe  nuclear  accident,  the  environment 
may be contaminated with airborne radioactive materials. 
These  may  deposit  on  the  plants.  Their  activity 
concentration and the type of radioactive contamination 
can  Leaves  of  medicinal  plants.  Their  activity 
concentration and the type of radioactive contamination 
can be measured by the radiation monitoring laboratories 
of  most  of  the  WHO  Member  States.  The  activity 
concentration  of  radioisotopes  in  herbs  should  be 
assessed  by  The  competent  national  radio  hygiene 
laboratories taking into account the relevant International 
Atomic Energy Agency (IAEA), FAO and WHO. Since 
radionuclide’s from accidental discharges vary with the 
type  of  facility  involved,  a  generalized  method  of 
measurement is not yet available. However, should such 
contamination  be  a  concern,  suspect  samples  can  be 
analysed by a competent laboratory. Details of laboratory 
techniques are available from the IAEA.
32 
Determination of aflatoxins 
Determination of aﬂatoxins should take place after using 
a suitable clean-up procedure, during which great care 
should be taken not to become exposed or to expose the 
working or general environment to these dangerous and 
toxic substances. Thus Member States should adapt their 
good  practices  for  national  pharmaceutical  control 
laboratories  and  GMP  accordingly.  Only  products that 
have  a  history  of  aﬂatoxin  contamination  need  to  be 
tested. 
There  are  speciﬁc  sampling  problems  especially  of 
aﬂatoxins  due  to  the  way  in  which  contamination 
spreads, as described for some food commodities, such 
as  nuts  and  corn.  This  may  need  to  be  taken  into 
consideration  when  sampling,  for  example  in  terms  of 
sample selection and sample size, and when the analysis 
is made. 
Tests for aﬂatoxins are designed to detect the possible 
presence of aﬂatoxins B , B , G and G , which are highly 
toxic contaminants in any material of plant origin. 
Some examples of proposed national limits for aﬂatoxin 
in various types of herbal products are presented in Box 
1  below.  Country  ﬁgures  are  based  on  information 
provided by national health authorities.
33 
Determination of microbiological contaminants 
Microbial  contamination  limits  in  herbal  materials, 
preparation and finished products 
Differential limits are set according to the intended use 
of herbal material and the medicines themselves. Some 
example are given here.
34 
Raw medicinal plant and herbal materials intended 
for further processing 
For  contamination  of  raw  medicinal  plant,  and  herbal 
materials  intended  for  further  processing  (including 
additional  decontamination  by  a  physical  or  chemical 
process)  the  limits,  adapted  from  the  provisional 
guidelines  established  by  an  international consultative 
group  (35),  are  given  for  untreated  herbal  material 
harvested under acceptable hygienic conditions: 
· Escherichia coli, maximum 104 per gram 
· mould propagules, maximum 105 per gram 
· shigella, absence per gram or ml. 
Herbal materials that have been pretreated 
For herbal materials that have been pretreated (e.g. with Patel Parthik et al / IJRAP 2011, 2 (4) 1148-1154 
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boiling water as used  for  herbal teas and infusions) or 
that are used as topical dosage forms, the limits are: 
· aerobic bacteria, maximum 107 per gram 
· yeasts and moulds, maximum 104 per gram 
· Escherichia coli, maximum 102 per gram 
· other enterobacteria, maximum 104 per gram 
· clostridia, absence per 1 gram 
· salmonellae, absence per 1 gram 
· shigella, absence per 1 gram. 
Other herbal materials for internal use 
For other herbal materials for internal use, the limits are: 
· aerobic bacteria, maximum 105 per gram 
· yeasts and moulds, maximum 103 per gram 
· Escherichia coli, maximum 10 per gram 
· other enterobacteria, maximum 103 per gram 
· clostridia, absence per 1 gram 
· salmonellae, absence per 1 gram 
· shigella, absence per 1 gram. 
Herbal  medicines  to  which  boiling  water  is  added 
before use 
For  herbal  medicines  to  which  boiling  water  is  added 
before use, the limits are: 
· aerobic bacteria, maximum 107 per gram 
· yeasts and moulds, maximum 104 per gram 
· Escherichia coli, maximum 10 per gram 
· other enterobacteria, maximum 103 per gram 
· clostridia, absence per 1 gram 
· salmonellae, absence per 1 gram 
· shigella, absence per 1 gram. 
Other herbal medicines 
For other herbal medicines, the limits are: 
· aerobic bacteria, maximum 105 per gram 
· yeasts and moulds, maximum 103 per gram 
· Escherichia coli, absence per 1 gram 
· other enterobacteria, maximum 103 per gram 
· clostridia, absence per 1 gram
34 
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Table:1 Contaminants and residue in herbal in medicine 
 
Contaminents: 
General classification  Group  Sub group  Specific example  Possible sources  Stages of 
production at 
which detectable* 
Chemical 
contaminants: 
Toxic and 
hazardous 
materials: 
Toxic metals & 
non metals 
Lead, cadmium, mercury, 
chromium 
Polluted soil & water during 
cultivation growth, mfg process 
1,2,3,4 
Persistent 
org.pollutants 
Dioxin aldrin, chlordane  Polluted air soil and water  1,2,3,4 
Radionuclide  Cs-134, 
Cs-137 
Air, soil, water during cultivation  1,2,3,4 
Biological 
toxins 
Mycotoxins  harvest process transportation & 
storage 
2,3,4 
Bacterial endotoxins  “  1,2,3,4 
Biological 
contaminants: 
Micro-organism  Becteria  S.aureous 
P.aeruginosa 
E.coli 
Shigella & salmonella sp. 
Soil, post harvest process 
transportation & storage 
1,2,3,4 
Fungi  Yeast, moulds  “  1,2,3,4 
Animals  Parasites  Protozoa, amoebae, 
helminthes 
Soil, excreta; organic farming; / 
cultivation mfg process 
1,3,4 
Insects  Cockroach & its part  post harvest process transportation 
& storage 
1,2,4 
Other  Mouse excreta 
earthworms, acarus 
“  1,2,4 
Solvents:  Org. solvents  Acetone, methanol, 
ethanol, butanol 
Soil & water during cultivation / 
growth mfg process 
1,2,3,4 
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Residues: 
General 
classification 
Group  Subgroup  Specific example  Possible source  Stages of production at 
which detectable* 
Agrochemical 
residues 
Pesticides  Insecticides  Carbamate, chlorinated, 
hydrocarbon, 
organophosphorous 
Air, soil, water during 
cultivation/ growth post 
harvest process 
1,2,3,4 
Herbicides  2,4-D, 2,4,5-T  Air, soil, water during 
cultivation/ growth post 
harvest process 
1,2,3,4 
Fungicides  dithiocarbamate  Air, soil, water during 
cultivation/ growth 
1,2,3,4 
Fumigants  Chemical 
agents 
Ethylene oxide, phosphine, 
methyl bromide, sulfur 
dioxide 
Post harvest process  2,3,4 
Disease 
control agents 
Antiviral 
agents 
Thiamethoxam  During cultivation  1,2,3,4 
Residual solvents  Org. solvents  Acetone, methanol, 
ethanol, butanol 
Mfg process  3,4 
*Stages of production at which detectable: 1- medicinal plants; 2- herbal plants; 3-finished herbal products.
3 
 
Table:2 example of national limits for arsenic and toxic metals in herbal medicines and products 
 
  Arsenic 
(As) 
Lead 
(Pb) 
Cadmium 
(Cd) 
Chromium 
(Cr) 
Mercury 
(Hg) 
Copper 
(cu) 
Total 
toxic 
metals as 
lead 
For herbal medicines: 
Canada  Herbal 
material 
5 ppm  10 ppm  0.3 ppm  2 ppm  0.2 ppm     
Finished 
products 
0.01 mg/day  0.02 mg/day  0.06 mg/day  0.02 mg/day  0.02 mg/day     
China  Herbal 
materials 
2 ppm  10 ppm  1 ppm    0.5 ppm    20 ppm 
Malaysia  Finished 
herbal 
products 
5 mg/kg  10 mg/kg      0.5 mg/kg     
Thailand  Herbal 
material 
4 ppm  10 ppm  0.3 ppm         
WHO recommendation    10mg/kg  0.3  mg/kg         
For other herbal products: 
National Sanitation 
Foundation Draft 
Proposal(raw dietary 
supplements) 
5 ppm  10 ppm  0.3 ppm  2 ppm       
National Sanitation 
Foundation Draft 
Proposal(finished dietary 
splmnts) 
0.01 
mg/daily 
0.02 mg/day  0.006 mg/day  0.03 mg/day  0.02 mg/day     
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